Symposium on pharmacologic and clinical control of cardiovascular drugs. Comments from the Food and Drug Administration.
D001682:Biological Availability; D004077:Digoxin / Q000592:standards*; D013607:Tablets; D014481:United States; D014486:United States Food and Drug Administration
D013607:Tablets; D004077:Digoxin